Holen Sie sich die Stockscreener-App
2.69
1.10%
-0.03
Handel nachbörslich:
2.75
0.06
+2.23%
Finanzdaten der Jasper Therapeutics Inc-Aktie (JSPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
13.77%
21.80
|
25.29 | 19.89 | 15.99 | 15.07 |
| Depreciation and Amortization |
13.88%
0.279
|
0.245 | 0.50 | 0.30 | 0.288 |
| Operating Income/Loss |
13.77%
-21.80
|
-25.29 | -19.89 | -15.99 | -15.07 |
| Nonoperating Income/Loss |
41.80%
0.561
|
0.964 | 1.252 | 1.41 | 1.344 |
| Income/Loss From Continuing Operations Before Tax |
12.66%
-21.24
|
-24.32 | -18.64 | -14.58 | -13.73 |
| Income/Loss From Continuing Operations After Tax |
12.66%
-21.24
|
-24.32 | -18.64 | -14.58 | -13.73 |
|
Net Income/Loss
|
12.66%
-21.24
|
-24.32 | -18.64 | -14.58 | -13.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10,462%
15.02
|
0.1422 | 15.00 | 14.99 | 13.33 |
| Diluted Average Shares |
10,462%
15.02
|
0.1422 | 15.00 | 14.99 | 13.33 |
| Basic Earnings Per Share |
14.02%
-1.41
|
-1.64 | -1.24 | -0.97 | -1.03 |
| Diluted Earnings Per Share |
14.02%
-1.41
|
-1.64 | -1.24 | -0.97 | -1.03 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):